Osaic Holdings
CVKD icon

Osaic Holdings’s Cadrenal Therapeutics CVKD Stock Holding History

Osaic Holdings’s Portfolio CVKD Stock Details CVKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
300
– – ﹤0.01% 7486
2026
Q1 		$1.54K Sell
300
-200
-40% -$1.4K ﹤0.01% 7132
2025
Q4 		$3.39K Hold
500
– – ﹤0.01% 6893
2025
Q3 		$6.48K Hold
500
– – ﹤0.01% 6609
2025
Q2 		$6.03K Sell
500
-1,000
-67% -$14.9K ﹤0.01% 6438
2025
Q1 		$26.4K Buy
1,500
+1,000
+200% +$18.4K ﹤0.01% 5167
2024
Q4 		$7.25K Buy
+500
New +$7.22K ﹤0.01% 5981

Other funds holding CVKD

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Osaic Holdings's CVKD Position: Q2 2026 in Review

Osaic Holdings held its Cadrenal Therapeutics (CVKD) position steady in Q2 2026 at 300 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #7486.

Osaic Holdings first reported a position in CVKD in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.4K in Q1 2025. 20 funds tracked by Wall St. Rank hold CVKD as of Q2 2026.

  • Osaic Holdings held 300 shares of Cadrenal Therapeutics worth $1K as of Q2 2026.
  • Osaic Holdings left its Cadrenal Therapeutics share count unchanged in Q2 2026.
  • Cadrenal Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7486 holding.
  • Osaic Holdings first reported a position in Cadrenal Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Cadrenal Therapeutics position peaked at $26.4K in Q1 2025.
  • 20 funds tracked by Wall St. Rank held Cadrenal Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.